{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:08:26Z","timestamp":1776118106632,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1038\/nm0798-822","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T02:15:09Z","timestamp":1092881709000},"page":"822-826","source":"Crossref","is-referenced-by-count":750,"title":["\u03b2-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy"],"prefix":"10.1038","volume":"4","author":[{"given":"Claudio","family":"Soto","sequence":"first","affiliation":[]},{"given":"Einar M.","family":"Sigurdsson","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Morelli","sequence":"additional","affiliation":[]},{"given":"R.","family":"Asok Kumar","sequence":"additional","affiliation":[]},{"given":"Eduardo M.","family":"Casta\u00f1o","sequence":"additional","affiliation":[]},{"given":"Blas","family":"Frangione","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0798822_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1046\/j.1471-4159.1994.63041191.x","volume":"63","author":"C Soto","year":"1994","unstructured":"Soto, C., Branes, M.C., Alvarez, J. & Inestrosa, N.C. Structural determinants of the Alzheimer's amyloid beta-peptide. J Neurochem. 63, 1191\u20131198 (1994).","journal-title":"J Neurochem."},{"key":"BFnm0798822_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"CJ Pike","year":"1993","unstructured":"Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state J. Neurosci. 13, 1676\u20131687 (1993).","journal-title":"J. Neurosci."},{"key":"BFnm0798822_CR3","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA. 91, 12243\u201312247 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFnm0798822_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","volume":"16","author":"BA Yankner","year":"1996","unstructured":"Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16, 921\u2013932 (1996).","journal-title":"Neuron."},{"key":"BFnm0798822_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","volume":"226","author":"C Soto","year":"1996","unstructured":"Soto, C., Kindy, M.S., Baumann, M. & Frangione, B. Inhibition of Alzheimer's amyloidosis by peptides that prevent \u03b2-sheet conformation. Biochem. Biophys. Res. Commun. 226, 672\u2013680 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm0798822_CR6","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1074\/jbc.270.7.3063","volume":"270","author":"C Soto","year":"1995","unstructured":"Soto, C., Casta\u00f1o, E.M., Frangione, B. & Inestrosa, N.C. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063\u20133067 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnm0798822_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0022-2836(92)90835-8","volume":"228","author":"C Hilsich","year":"1992","unstructured":"Hilsich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease \u03b2A4 peptides. J. Mol. Biol. 228, 460\u2013473 (1992).","journal-title":"J. Mol. Biol."},{"key":"BFnm0798822_CR8","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1021\/bi00015a033","volume":"34","author":"JP Lee","year":"1995","unstructured":"Lee, J.P. et al. H-1 NMR of A-beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry 34, 5191\u20135200 (1995).","journal-title":"Biochemistry"},{"key":"BFnm0798822_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/bi00003a003","volume":"34","author":"JD Wood","year":"1995","unstructured":"Wood, J.D., Wetzel, R., Martin, J.D. & Hurle, M.R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide \/A4. Biochemistry 34, 724\u2013730 (1995).","journal-title":"Biochemistry"},{"key":"BFnm0798822_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.bi.47.070178.001343","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou, P.Y. & Fasman, G.D. Empirical predictions of protein conformation. Ann. Rev. Biochem. 47, 251\u2013276 (1978).","journal-title":"Ann. Rev. Biochem."},{"key":"BFnm0798822_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0014-5793(95)00863-5","volume":"371","author":"C Soto","year":"1995","unstructured":"Soto, C., Casta\u00f1o, E.M., Prelli, F., Kumar, R.A. & Baumann, M. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Letters 371, 110\u2013114 (1995).","journal-title":"FEBS Letters"},{"key":"BFnm0798822_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1006\/jmbi.1996.0133","volume":"256","author":"SJ Wood","year":"1996","unstructured":"Wood, S.J., Maleeff, B., Hart, T. & Wetzel, R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide AP. J. Mol. Biol. 256, 870\u2013877 (1996).","journal-title":"J. Mol. Biol."},{"key":"BFnm0798822_CR13","first-page":"373","volume":"45","author":"LK Simmons","year":"1994","unstructured":"Simmons, L.K. et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373\u2013379 (1994).","journal-title":"Mol. Pharmacol."},{"key":"BFnm0798822_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0197-4580(96)00169-8","volume":"17","author":"EM Sigurdsson","year":"1996","unstructured":"Sigurdsson, E.M., Lorens, S.A., Hejna, M.J., Dong, X.W. & Lee, J.M. Local and distant histopathological effects of unilateral amyloid- 25\u201335 injections into the amygdala of young F344 rats. Neurobiol. Aging. 17, 893\u2013901 (1996).","journal-title":"Neurobiol. Aging."},{"key":"BFnm0798822_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0197-4580(97)00154-1","volume":"18","author":"EM Sigurdsson","year":"1997","unstructured":"Sigurdsson, E.M., Lee, J.M., Dong, X.W., Hejna, M.J. & Lorens, S.A. Bilateral injections of Amyloid-\u03b2 25\u201335 into the amygdala of young fischer rats: Behavioral, neurochemical and time dependent histopathological effects. Neurobiol. Aging 18, 591\u2013608 (1997).","journal-title":"Neurobiol. Aging"},{"key":"BFnm0798822_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. & Hyman, B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631\u2013639 (1992).","journal-title":"Neurology"},{"key":"BFnm0798822_CR17","first-page":"1","volume":"1","author":"A Jimenez-Huete","year":"1998","unstructured":"Jimenez-Huete, A. et al. Antibodies directed to the carboxyl terminus of amyloid beta peptide recognize sequence epitopes and distinct immunoreactive deposits in Alzheimer's disease brain. Alzheimer's Report 1, 1\u20137 (1998).","journal-title":"Alzheimer's Report"},{"key":"BFnm0798822_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F -amyloid precursor protein. Nature 373, 523\u2013527 (1995).","journal-title":"Nature"},{"key":"BFnm0798822_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"KK Hsiao","year":"1996","unstructured":"Hsiao, K.K. et al. Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice. Science 274, 99\u2013102 (1996).","journal-title":"Science"},{"key":"BFnm0798822_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L Holcomb","year":"1998","unstructured":"Holcomb, L. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med. 4, 97\u2013100 (1998).","journal-title":"Nature Med."},{"key":"BFnm0798822_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","volume":"302","author":"GG Glenner","year":"1980","unstructured":"Glenner, G.G. Amyloid deposits and amyloidosis. The \u03b2-fibrilloses. N. Engl. J. Med. 302, 1283\u20131292 (1980).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0798822_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A., Razzaboni, B., Weir, G.C. & Yankner, B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756\u2013760 (1994).","journal-title":"Nature"},{"key":"BFnm0798822_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/362543a0","volume":"362","author":"G Forloni","year":"1993","unstructured":"Forloni, G. et al. Neurotoxicity of a prion protein fragment. Nature 362, 543\u2013546 (1993).","journal-title":"Nature"},{"key":"BFnm0798822_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nbt0397-258","volume":"15","author":"WP Esler","year":"1997","unstructured":"Esler, W.P. et al. A\u03b2 deposition inhibitor screen using synthetic amyloid. Nature Biotechnol. 15, 258\u2013263 (1997).","journal-title":"Nature Biotechnol."},{"key":"BFnm0798822_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0197-4580(94)90105-8","volume":"15","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski, T., Ghiso, J. & Frangione, B. Alzheimer's disease and soluble A\u03b2. Neurobiol. Aging. 15, 143\u2013152 (1994).","journal-title":"Neurobiol. Aging"},{"key":"BFnm0798822_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0968-0004(00)89100-8","volume":"20","author":"PJ Thomas","year":"1995","unstructured":"Thomas, P.J., Qu, B. & Pedersen, P.L. Defective protein folding as a basis of human disease. Trends Biochem. Sci. 20, 456\u2013459 (1995).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm0798822_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0959-440X(96)80089-3","volume":"6","author":"JW Kelly","year":"1996","unstructured":"Kelly, J.W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6, 11\u201317 (1996).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnm0798822_CR28","unstructured":"Soto, C. et al. Reversal of disease-specific prion protein conformation and protease-resistance by peptides designed as \u03b2-sheet breakers. (Manuscript submitted)."},{"key":"BFnm0798822_CR29","unstructured":"Janossy, G., Greaves, M.F., Doenhoff, M.J. & Snajder, J. Lymphocyte activation. Quantitation of the proliferative response to mitogens using defined T and B cell populations. Clin. Exp. Immunol. 14, 581 (1973)."},{"key":"BFnm0798822_CR30","first-page":"17.1","volume-title":"Current Protocols in Immunology","author":"CR Duke","year":"1995","unstructured":"Duke, CR, et al. in Current Protocols in Immunology (eds. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and Strober, W) 17.1\u201317.33 (John Wiley & Sons, New York, 1995)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0798-822","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0798-822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0798-822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:26:48Z","timestamp":1684452408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0798-822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["BFnm0798822"],"URL":"https:\/\/doi.org\/10.1038\/nm0798-822","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}